+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antidepressants Drugs Market by Drug Class (Atypical Antidepressant, Monoamine Oxidase Inhibitor, Selective Serotonin Reuptake Inhibitor), Product Type (Branded, Generic), Administration Route, Distribution Channel, Therapeutic Application - Global Forecast 2025-2030- Product Image
Antidepressants Drugs Market by Drug Class (Atypical Antidepressant, Monoamine Oxidase Inhibitor, Selective Serotonin Reuptake Inhibitor), Product Type (Branded, Generic), Administration Route, Distribution Channel, Therapeutic Application - Global Forecast 2025-2030- Product Image
Sale

Antidepressants Drugs Market by Drug Class (Atypical Antidepressant, Monoamine Oxidase Inhibitor, Selective Serotonin Reuptake Inhibitor), Product Type (Branded, Generic), Administration Route, Distribution Channel, Therapeutic Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715760
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Antidepressant Drugs Market is undergoing rapid transformation as innovative therapies and advanced technologies emerge to address evolving global mental health challenges. Senior decision-makers face shifting treatment paradigms, regulatory pressures, and complex supply dynamics that are shaping opportunities and risks in this dynamic sector.

Market Snapshot: Antidepressant Drugs Market Growth and Outlook

The Antidepressant Drugs Market grew from USD 22.44 billion in 2024 to USD 24.80 billion in 2025. It is projected to expand at a CAGR of 10.12%, reaching USD 40.03 billion by 2030. This growth reflects rapidly increasing demand for new antidepressant classes, digital health integration, and regional market expansion. The sector is evolving through scientific innovation, diversified delivery mechanisms, and robust investment in supply chain adaptation amidst a shifting global regulatory landscape.

Scope & Segmentation: Comprehensive Coverage of Market Segments and Regional Insights

  • Drug Classes: Includes atypical antidepressants such as bupropion, mirtazapine, trazodone, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, and tricyclic antidepressants.
  • Product Types: Covers both branded and generic formulations, with differentiation based on delivery technologies and support programs.
  • Administration Routes: Encompasses oral, parenteral, and transdermal options, catering to varied clinical needs and patient preferences.
  • Distribution Channels: Involves hospital, online, and retail pharmacy networks to maximize accessibility and engagement.
  • Therapeutic Applications: Addresses bipolar depression, generalized anxiety disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder, major depressive disorder—including postpartum and treatment-resistant forms—obsessive compulsive disorder, and seasonal affective disorder.
  • Regional Coverage: Analyzes major geographies, including the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (major EU states, Middle East countries, African nations), and Asia-Pacific (China, India, Japan, Australia, Southeast Asian markets).
  • Technology Integrations: Explores adoption of digital platforms, advances in drug formulation, artificial intelligence-supported research, and real-time patient monitoring tools.
  • Key Companies: Includes core industry participants such as Eli Lilly and Company, Pfizer Inc., AbbVie Inc., GlaxoSmithKline plc, H. Lundbeck A/S, Otsuka Pharmaceutical, Johnson & Johnson, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, and Cipla Limited.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Market expansion is driven by notable shifts to patient-centered therapies and diversification of drug development pipelines targeting previously unmet mental health needs.
  • Pharmaceutical stakeholders are adopting adaptive procurement and manufacturing strategies in response to evolving trade and regulatory frameworks.
  • The rise of digital therapeutics and telehealth solutions is creating new avenues for patient engagement, offering clinicians real-time data to optimize treatment pathways.
  • Advancements in formulation science, including alternative delivery routes, are enhancing both patient adherence and care outcomes.
  • Regional disparities in reimbursement models, healthcare infrastructure, and regulatory standards require tailored approaches to market entry and expansion.
  • Collaborative strategies, leveraging partnerships with contract manufacturing and research organizations, are consolidating industry positioning and operational resilience.

Tariff Impact: United States Policy Shifts and Supply Chain Adaptation

Recent tariff introductions in the United States have prompted pharmaceutical companies to re-examine sourcing strategies for antidepressant ingredients and finished products. These changes are leading to increased investment in alternate supply networks, near-shoring production, and enhanced supply chain transparency. Manufacturers are optimizing batch production and leveraging strategic alliances to ensure ongoing availability of essential therapies while navigating complex trade environments.

Methodology & Data Sources

This analysis applies a multi-level research framework combining structured interviews, clinician surveys, executive briefings, and secondary research from industry archives, regulatory filings, and academic literature. Additional evaluation methods include value chain analysis, competitive benchmarking, and sensitivity analyses to ensure robustness and credibility.

Why This Report Matters

  • Enables strategic decisions on investment, expansion, and partnership opportunities within a rapidly growing mental health pharmaceutical segment.
  • Supports proactive risk mitigation in response to evolving trade, regulatory, and operational landscapes.
  • Delivers actionable intelligence on emerging therapeutics, technology adoption, and competitive positioning.

Conclusion

This report delivers a thorough overview of the antidepressant drugs market, highlighting critical developments, evolving strategies, and actionable insights. Senior leaders can leverage these findings to position their organizations for success in an increasingly complex and dynamic global environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid expansion of esketamine nasal spray adoption for treatment-resistant depression
5.2. Integration of digital therapeutic platforms with traditional antidepressant prescription protocols
5.3. Growing utilization of pharmacogenomic testing to personalize SSRI and SNRI treatment regimens
5.4. Regulatory approvals driving off-label antidepressant use in adolescent and geriatric populations
5.5. Rising telepsychiatry adoption reshaping antidepressant prescription and patient adherence rates
5.6. Emergence of psychedelic-assisted therapies such as psilocybin microdosing for refractory depression
5.7. Intensifying pricing pressures from generic SSRI manufacturers in mature markets worldwide
5.8. Increased investment in NMDA receptor modulators and novel mechanism antidepressant pipelines
5.9. Surge in antidepressant demand across Asia-Pacific driven by mental health awareness campaigns
5.10. Development of AI-powered monitoring tools to track patient response and side effect profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antidepressants Drugs Market, by Drug Class
8.1. Introduction
8.2. Atypical Antidepressant
8.2.1. Bupropion
8.2.2. Mirtazapine
8.2.3. Trazodone
8.3. Monoamine Oxidase Inhibitor
8.4. Selective Serotonin Reuptake Inhibitor
8.5. Serotonin Noradrenaline Reuptake Inhibitor
8.6. Tricyclic Antidepressant
9. Antidepressants Drugs Market, by Product Type
9.1. Introduction
9.2. Branded
9.3. Generic
10. Antidepressants Drugs Market, by Administration Route
10.1. Introduction
10.2. Oral
10.3. Parenteral
10.4. Transdermal
11. Antidepressants Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Antidepressants Drugs Market, by Therapeutic Application
12.1. Introduction
12.2. Bipolar Depression
12.3. Generalized Anxiety Disorder
12.3.1. Panic Disorder
12.3.2. Post Traumatic Stress Disorder
12.3.3. Social Anxiety Disorder
12.4. Major Depressive Disorder
12.4.1. Postpartum Depression
12.4.2. Treatment Resistant Depression
12.5. Obsessive Compulsive Disorder
12.6. Seasonal Affective Disorder
13. Americas Antidepressants Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antidepressants Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antidepressants Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Eli Lilly and Company
16.3.2. Pfizer Inc.
16.3.3. AbbVie Inc.
16.3.4. GlaxoSmithKline plc
16.3.5. H. Lundbeck A/S
16.3.6. Otsuka Pharmaceutical Co., Ltd.
16.3.7. Johnson & Johnson
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Sun Pharmaceutical Industries Ltd.
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIDEPRESSANTS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIDEPRESSANTS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIDEPRESSANTS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIDEPRESSANTS DRUGS MARKET: RESEARCHAI
FIGURE 26. ANTIDEPRESSANTS DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIDEPRESSANTS DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIDEPRESSANTS DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIDEPRESSANTS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY BUPROPION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY BUPROPION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MIRTAZAPINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MIRTAZAPINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TRAZODONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TRAZODONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MONOAMINE OXIDASE INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MONOAMINE OXIDASE INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SEROTONIN NORADRENALINE REUPTAKE INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SEROTONIN NORADRENALINE REUPTAKE INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY BIPOLAR DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY BIPOLAR DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY POST TRAUMATIC STRESS DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY POST TRAUMATIC STRESS DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SOCIAL ANXIETY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SOCIAL ANXIETY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY POSTPARTUM DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY POSTPARTUM DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SEASONAL AFFECTIVE DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY SEASONAL AFFECTIVE DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 114. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 115. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 116. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 117. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 120. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 121. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 126. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 127. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 128. CANADA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 225. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 226. GERMANY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 242. FRANCE ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 259. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 260. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 261. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 262. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 263. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 266. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 267. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 272. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 273. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 274. ITALY ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 289. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 290. SPAIN ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES ANTIDEPRESSANTS DRUGS MARKET SIZE, BY MAJOR DEPRESSIVE DISORDER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ANTIDEPRESSANTS DRUGS MARKET SIZE, BY ATYPICAL ANTIDEPRESSANT, 2025

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antidepressants Drugs market report include:
  • Eli Lilly and Company
  • Pfizer Inc.
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • H. Lundbeck A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 24.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 40.03 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antidepressant Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Antidepressant Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 140 Pages
  • Global
From
Antidepressants Market Report 2025 - Product Image

Antidepressants Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Antidepressant Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Antidepressants - Global Strategic Business Report - Product Image

Antidepressants - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Antidepressants Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Image

Antidepressants Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • 86 Pages
  • Global
From

About the Antidepressant Market

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression. Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.